Form 8-K - Current report:
SEC Accession No. 0001683168-23-008204
Filing Date
2023-11-16
Accepted
2023-11-15 20:45:49
Documents
19
Period of Report
2023-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT pharmacyte_8k.htm   iXBRL 8-K 38870
2 FORM OF SERIES A WARRANT pharmacyte_ex0401.htm EX-4.1 157767
3 FORM OF SERIES B WARRANT pharmacyte_ex0402.htm EX-4.2 157980
4 FORM OF PURCHASE AGREEMENT pharmacyte_ex1001.htm EX-10.1 299648
5 FORM OF CONVERTIBLE NOTE pharmacyte_ex1002.htm EX-10.2 243839
6 FORM OF REGISTRATION RIGHTS AGREEMENT pharmacyte_ex1003.htm EX-10.3 126154
7 FORM OF COLLABORATION AGREEMENT pharmacyte_ex1004.htm EX-10.4 86794
8 PRESS RELEASE pharmacyte_ex9901.htm EX-99.1 11371
  Complete submission text file 0001683168-23-008204.txt   1568027

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE pmcb-20231114.xsd EX-101.SCH 3079
10 XBRL LABEL FILE pmcb-20231114_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE pmcb-20231114_pre.xml EX-101.PRE 22363
13 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_8k_htm.xml XML 3311
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 231412219
SIC: 2836 Biological Products, (No Diagnostic Substances)